Effects of Two Alcohol Reduction Interventions on Depression and Anxiety Symptoms of ART Clients in Vietnam.

Alcohol reduction intervention Antiretroviral therapy Anxiety Depression Hazardous alcohol use People with HIV Vietnam

Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Jun 2022
Historique:
accepted: 06 11 2021
pubmed: 23 11 2021
medline: 30 4 2022
entrez: 22 11 2021
Statut: ppublish

Résumé

Little is known about the potential mental health impacts of cognitive behavioral therapy and motivational interviewing interventions that focus on alcohol reduction among people with HIV (PWH). Our study aimed to assess the impact of two evidence-based alcohol reduction interventions on depression and anxiety symptoms of antiretroviral therapy (ART) clients with hazardous alcohol use. We conducted a secondary data analysis of data from a three-arm randomized controlled trial among ART clients in Thai Nguyen, Vietnam that evaluated the impacts of two alcohol reduction interventions in Vietnam. ART clients 18 years old or more with hazardous alcohol use (based on the Alcohol Use Disorders Identification Test-Consumption) were enrolled and randomized into one of three arms: Combined intervention, Brief intervention, and Standard of care (SOC). Symptoms of depression, measured with the Patient Health Questionnaire-9, and anxiety, measured with the Generalized Anxiety Disorder-7 scale, were assessed at baseline and 3, 6, and 12 months post-intervention. Generalized estimating equations were used to evaluate the effects of the interventions on depression and anxiety symptoms. The prevalence of depression and anxiety symptoms at baseline was 25.1% and 16.1%, respectively. Decreases in depression and anxiety symptoms were observed in all three arms from baseline to 12-month follow-up. There were no significant differences in depression and anxiety symptoms among participants receiving either intervention, relative to the SOC. Interventions with a dual focus on alcohol and mental health are needed to achieve more pronounced and sustainable improvements in depression and anxiety symptoms for PWH with hazardous alcohol use.

Identifiants

pubmed: 34807321
doi: 10.1007/s10461-021-03532-1
pii: 10.1007/s10461-021-03532-1
pmc: PMC10144180
mid: NIHMS1883345
doi:

Substances chimiques

Ethanol 3K9958V90M

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1829-1840

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI050410
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI140854
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA037440
Pays : United States
Organisme : NIDA NIH HHS
ID : R01DA037440
Pays : United States

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

AIDS. 2015 Jun 1;29(9):1087-96
pubmed: 25870981
BMC Public Health. 2014 Jul 18;14:731
pubmed: 25037953
AIDS Care. 2015;27(9):1174-82
pubmed: 26197063
J Clin Epidemiol. 2014 Mar;67(3):267-77
pubmed: 24275499
J Subst Abuse Treat. 2016 Oct;69:57-63
pubmed: 27568511
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219854368
pubmed: 31185787
Addict Behav. 2018 Oct;85:88-93
pubmed: 29879611
East Asian Arch Psychiatry. 2019 Mar;29(1):20-25
pubmed: 31237253
Afr J AIDS Res. 2018 Dec;17(4):293-300
pubmed: 30466364
Curr HIV/AIDS Rep. 2014 Sep;11(3):291-307
pubmed: 25038748
BMC Med Res Methodol. 2007 Jul 03;7:30
pubmed: 17608932
Alcohol Res. 2012;34(4):414-31
pubmed: 23584108
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
J Consult Clin Psychol. 2005 Apr;73(2):249-61
pubmed: 15796632
J Pain Symptom Manage. 2010 Jul;40(1):31-4
pubmed: 20619211
J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):159-66
pubmed: 17146374
EClinicalMedicine. 2020 May 27;23:100333
pubmed: 32637890
Clin Psychol Rev. 2000 Mar;20(2):149-71
pubmed: 10721495
Psychosom Med. 2012 Nov-Dec;74(9):883-90
pubmed: 22923701
Drug Alcohol Depend. 1996 Sep;42(1):49-54
pubmed: 8889403
Subst Use Misuse. 2017 Sep 19;52(11):1411-1419
pubmed: 28436758
JAMA. 1990 Nov 21;264(19):2511-8
pubmed: 2232018
BMC Infect Dis. 2017 Apr 11;17(1):263
pubmed: 28399823
AIDS Care. 2016;28 Suppl 1:56-9
pubmed: 26888472
Addict Biol. 2017 Sep;22(5):1119-1159
pubmed: 27353220
Drug Alcohol Depend. 2013 Jan 1;127(1-3):39-44
pubmed: 22749565
Subst Abuse Treat Prev Policy. 2019 Sep 18;14(1):39
pubmed: 31533764
Arch Intern Med. 1999 Aug 9-23;159(15):1681-9
pubmed: 10448769
Sci Rep. 2017 Nov 14;7(1):15489
pubmed: 29138432
AIDS Behav. 2015 Jun;19(6):981-6
pubmed: 25331267
Addict Behav. 2018 Sep;84:110-117
pubmed: 29660593
PLoS One. 2014 Mar 11;9(3):e90723
pubmed: 24618892
Br J Addict. 1989 Nov;84(11):1353-7
pubmed: 2597811
Subst Use Misuse. 2001 Feb;36(3):313-31
pubmed: 11325169
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
AIDS Behav. 2017 Nov;21(Suppl 2):126-143
pubmed: 28831609
Harm Reduct J. 2019 Jan 17;16(1):6
pubmed: 30654814
AIDS Care. 2015;27(2):142-9
pubmed: 25277328
J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):443-50
pubmed: 18077833
Int J Ment Health Syst. 2019 Jul 16;13:48
pubmed: 31341512
Arch Gen Psychiatry. 1994 Jan;51(1):39-49
pubmed: 8279928
PLoS One. 2020 Sep 30;15(9):e0240008
pubmed: 32997705
AIDS Care. 2000 Jun;12(3):333-41
pubmed: 10928211
JAMA Netw Open. 2020 Sep 1;3(9):e2017115
pubmed: 32945875
Alcohol Alcohol. 1998 May-Jun;33(3):291-303
pubmed: 9632055
Diabetes Educ. 2016 Dec;42(6):728-738
pubmed: 27831524
Alcohol Alcohol. 2015 Jul;50(4):463-9
pubmed: 25802055
J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):137-45
pubmed: 25967270
Int J Environ Res Public Health. 2018 Dec 17;15(12):
pubmed: 30562949
Int J STD AIDS. 2015 Mar;26(3):165-72
pubmed: 24759561
Int J Environ Res Public Health. 2015 Oct 30;12(11):14021-33
pubmed: 26529004
AIDS Behav. 2019 Aug;23(8):2059-2071
pubmed: 30659424
AIDS Patient Care STDS. 2016 Apr;30(4):185-92
pubmed: 27028184
Subst Use Misuse. 2018 Jun 7;53(7):1084-1092
pubmed: 29537932
BJPsych Open. 2016 Jun;2(3):221-232
pubmed: 27458524
Int J STD AIDS. 2017 Jun;28(7):651-659
pubmed: 27448655
AIDS Res Ther. 2016 Nov 15;13:39
pubmed: 27891160
BMC Public Health. 2009 Aug 18;9:298
pubmed: 19689799
AIDS Care. 2018 Jul;30(7):888-895
pubmed: 29471677
AIDS Behav. 2012 Nov;16(8):2101-18
pubmed: 22116638
Addiction. 2008 Sep;103(9):1461-7
pubmed: 18637000
BMC Psychiatry. 2016 Feb 29;16:55
pubmed: 26926690
AIDS Behav. 2018 Aug;22(8):2564-2574
pubmed: 29860556
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
AIDS Educ Prev. 2006 Feb;18(1):1-11
pubmed: 16539572
BMC Public Health. 2014 Feb 13;14:161
pubmed: 24524286
Drug Alcohol Depend. 2011 Sep 1;117(2-3):158-63
pubmed: 21345624
AIDS Behav. 2019 Mar;23(3):580-591
pubmed: 30269230
Curr Psychiatry Rep. 2015 Jan;17(1):530
pubmed: 25413636
Trop Med Int Health. 2016 May;21(5):654-61
pubmed: 26821247
AIDS Behav. 2011 Jan;15(1):209-13
pubmed: 20013042
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):589-597
pubmed: 27846072
AIDS Behav. 2016 Mar;20(3):566-72
pubmed: 26187007

Auteurs

M X Nguyen (MX)

Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Dr, Chapel Hill, NC, 27516, USA. binhminh@live.unc.edu.

H L Reyes (HL)

Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Dr, Chapel Hill, NC, 27516, USA.

B W Pence (BW)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

K E Muessig (KE)

Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Dr, Chapel Hill, NC, 27516, USA.

H E Hutton (HE)

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

C A Latkin (CA)

Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

D Dowdy (D)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

G Chander (G)

Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.

K E Lancaster (KE)

Department of Epidemiology, College of Public Health, Ohio State University, Columbus, OH, USA.

C Frangakis (C)

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

T Sripaipan (T)

Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Dr, Chapel Hill, NC, 27516, USA.

H V Tran (HV)

Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Dr, Chapel Hill, NC, 27516, USA.

V F Go (VF)

Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Dr, Chapel Hill, NC, 27516, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH